Rani Therapeutics Holdings, Inc. Class A Common Stock Share Price
NASDAQ: RANIHealthcare
Live Rani Therapeutics Holdings, Inc. Class A Common Stock Share Price Chart
O H L
Rani Therapeutics Holdings, Inc. Class A Common Stock Performance Overview
Days Range
▼
$0.82Low
$0.85High
Markets Today
| Previous Close | $0.85 |
|---|---|
| Open | $0.83 |
| Volume | 92,443 |
| Day's Range | $0.82 - $0.85 |
| 52W Range | $0.45 - $3.87 |
| Market Cap | $87.26 M |
Historical Performance
| 1M Returns | +3.17 |
|---|---|
| 3M Returns | +8.84 |
| 6M Returns | -28.44 |
| 1Y Returns | +76.83 |
| 5Y Returns | -95.46 |
| 10Y Returns | NA |
Rani Therapeutics Holdings, Inc. Class A Common Stock Fundamentals
| Market Cap | $87.26 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $1.63 M |
| ROE TTM | -1.70 |
| EPS TTM | $-0.27 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.63 |
| EBITDA | $-37.41 M |
| Profit Margin | -1817.09 |
| Market Cap | $87.26 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $1.63 M |
| ROE TTM | -1.70 |
| EPS TTM | $-0.27 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.63 |
| EBITDA | $-37.41 M |
| Profit Margin | -1817.09 |
Rani Therapeutics Holdings, Inc. Class A Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $172.00 K | $0 | $0 | $1.46 M | $1.71 M | $1.71 M |
| Gross Profit + | $172.00 K | $0 | $0 | $1.46 M | $1.71 M | $1.71 M |
| Operating Income | -$12.01 M | -$10.51 M | -$7.26 M | -$8.54 M | -$8.34 M | -$8.83 M |
| EBITDA | -$11.76 M | -$10.27 M | -$7.03 M | -$8.35 M | -$8.18 M | -$8.68 M |
| Interest Expense | -$943.00 K | -$877.00 K | -$725.00 K | -$347.00 K | -$88.00 K | -$8.00 K |
| Depreciation | $251.00 K | $240.00 K | $223.00 K | $186.00 K | $161.00 K | $152.00 K |
| Income Before Tax | -$12.74 M | -$11.22 M | -$7.91 M | -$9.07 M | -$8.02 M | -$8.42 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$12.74 M | -$11.22 M | -$7.91 M | -$9.07 M | -$8.02 M | -$8.42 M |
| Net Profit Margin | -7405.81% | - | - | -621.08% | -469.26% | -493.03% |
Rani Therapeutics Holdings, Inc. Class A Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $5.00 K | $5.00 K | $6.00 K | $11.00 K | $11.00 K | $13.00 K |
| Reserve & Surplus | -$110.17 M | -$116.86 M | -$122.27 M | -$132.58 M | -$139.62 M | -$147.03 M |
| Non-Current Liabilities | $9.34 M | $5.43 M | $2.97 M | $4.44 M | $2.48 M | $2.22 M |
| Current Liabilities | $20.13 M | $20.62 M | $19.14 M | $12.67 M | $13.86 M | $10.64 M |
| Total Liabilities | $29.47 M | $26.05 M | $22.11 M | $17.11 M | $16.34 M | $12.86 M |
| Fixed Assets | $1.35 M | $1.14 M | $922.00 K | $736.00 K | $601.00 K | $525.00 K |
| Current Assets | $17.78 M | $11.07 M | $4.96 M | $53.32 M | $47.09 M | $56.52 M |
| Total Assets | $24.13 M | $16.90 M | $10.14 M | $58.62 M | $51.88 M | $60.84 M |
Rani Therapeutics Holdings, Inc. Class A Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$12.74 M | -$11.22 M | -$7.91 M | -$9.07 M | -$8.02 M | -$8.42 M |
| Operating Cash Flow | -$8.15 M | -$5.80 M | -$5.06 M | $294.00 K | -$6.50 M | -$9.03 M |
| Investing Cash Flow | $18.23 M | $5.71 M | $0 | -$30.97 M | -$2.45 M | -$14.56 M |
| Financing Cash Flow | -$3.73 M | $188.00 K | -$1.01 M | $44.85 M | -$27.00 K | $18.81 M |
| Change in Cash | $6.35 M | $105.00 K | -$6.07 M | $14.17 M | -$8.97 M | -$4.78 M |
Rani Therapeutics Holdings, Inc. Class A Common Stock Return Calculator
The Rani Therapeutics Holdings, Inc. Class A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$448
Invested Amount$10,000
Est. Returns$-9,552
About Rani Therapeutics Holdings, Inc. Class A Common Stock
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Popular Stocks
FAQs
What is the share price of Rani Therapeutics Holdings, Inc. Class A Common Stock today?
Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) share price as of September 18, 2026 is $0.84. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Rani Therapeutics Holdings, Inc. Class A Common Stock?
Yes, Indian Investors can invest in the Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) Share by opening an international trading account with Angel One.
How can I purchase Rani Therapeutics Holdings, Inc. Class A Common Stock shares in India?
Purchasing Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Rani Therapeutics Holdings, Inc. Class A Common Stock?
Yes, you can purchase fractional shares of Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Rani Therapeutics Holdings, Inc. Class A Common Stock?
The market capitalization of Rani Therapeutics Holdings, Inc. Class A Common Stock on September 18, 2026, is $87.26 M.
In which sector Rani Therapeutics Holdings, Inc. Class A Common Stock belongs?
Rani Therapeutics Holdings, Inc. Class A Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Rani Therapeutics Holdings, Inc. Class A Common Stock stocks?
In order to invest in Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
